TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biolit AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
13,031
|
14,035 | |
| Financial expenses |
1
|
0 | |
| Earnings before taxes |
1,149
|
815 | |
| EBITDA |
1,126
|
788 | |
| Total assets |
3,787
|
3,618 | |
| Current assets |
3,764
|
3,546 | |
| Current liabilities |
2,788
|
2,948 | |
| Equity capital |
1,000
|
670 | |
| - share capital |
9
|
9 | |
| Employees (average) |
39
|
40
|
44 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
26.4%
|
18.5% | |
| Turnover per employee |
326
|
319 | |
| Profit as a percentage of turnover |
8.8%
|
5.8% | |
| Return on assets (ROA) |
30.4%
|
22.5% | |
| Current ratio |
135.0%
|
120.3% | |
| Return on equity (ROE) |
114.9%
|
121.6% | |
| Change turnover |
-527
|
-340 | |
| Change turnover % |
10%
|
-4%
|
-2% |
| Chg. No. of employees |
-1
|
-4
|
-6 |
| Chg. No. of employees % |
-3%
|
-9%
|
-12% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.